Moody National Bank Trust Division Sells 1,267 Shares of Colgate-Palmolive (NYSE:CL)

Moody National Bank Trust Division lowered its stake in shares of Colgate-Palmolive (NYSE:CL – Get Rating) by 12.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,057 shares of the company’s stock after selling 1,267 shares during the quarter. Moody National Bank Trust Division’s holdings in Colgate-Palmolive were worth $713,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in CL. Dimensional Fund Advisors LP increased its position in shares of Colgate-Palmolive by 4.0% in the first quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock worth $185,376,000 after purchasing an additional 94,837 shares during the period. Covestor Ltd raised its position in shares of Colgate-Palmolive by 71.9% in the 1st quarter. Covestor Ltd now owns 2,451 shares of the company’s stock valued at $186,000 after buying an additional 1,025 shares in the last quarter. Mackenzie Financial Corp boosted its position in shares of Colgate-Palmolive by 8.5% during the 1st quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock worth $142,774,000 after acquiring an additional 146,936 shares in the last quarter. First Western Trust Bank bought a new position in Colgate-Palmolive in the first quarter valued at approximately $569,000. Finally, Wsfs Capital Management LLC acquired a new position in Colgate-Palmolive during the first quarter valued at approximately $288,000. Institutional investors own 77.63% of the company’s stock.

Colgate-Palmolive Stock Down 1.0 %

Shares of NYSE:CL opened at $72.20 on Friday. The firm has a market cap of $59.95 billion, a P/E ratio of 33.90, a P/E/G ratio of 3.79 and a beta of 0.48. The business has a fifty day simple moving average of $74.18 and a 200 day simple moving average of $75.04. The company has a quick ratio of 0.76, a current ratio of 1.28 and a debt-to-equity ratio of 10.84. Colgate-Palmolive has a 12-month low of $67.84 and a 12-month high of $83.81.

Colgate-Palmolive (NYSE:CL – Get Rating) last announced its earnings results on Friday, January 27th. The company reported $0.77 EPS for the quarter, meeting the consensus estimate of $0.77. The business had revenue of $4.63 billion for the quarter, compared to analysts’ expectations of $4.58 billion. Colgate-Palmolive had a return on equity of 317.08% and a net margin of 9.93%. The firm’s revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.79 earnings per share. Analysts predict that Colgate-Palmolive will post 3.1 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, May 15th. Shareholders of record on Friday, April 21st will be given a dividend of $0.48 per share. The ex-dividend date of this dividend is Thursday, April 20th. This represents a $1.92 dividend on an annualized basis and a yield of 2.66%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.47. Colgate-Palmolive’s dividend payout ratio is 88.26%.

Analyst Upgrades and Downgrades

CL has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reduced their target price on Colgate-Palmolive from $87.00 to $84.00 in a report on Monday, January 30th. Wells Fargo & Company lowered their target price on Colgate-Palmolive from $80.00 to $76.00 and set an “equal weight” rating for the company in a research note on Monday, January 30th. StockNews.com initiated coverage on shares of Colgate-Palmolive in a research note on Thursday. They issued a “hold” rating on the stock. Wolfe Research assumed coverage on shares of Colgate-Palmolive in a research report on Monday, November 21st. They set a “market perform” rating for the company. Finally, JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $81.00 to $86.00 and gave the company an “overweight” rating in a research report on Friday, January 13th. Six research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $82.09.

About Colgate-Palmolive

(Get Rating)

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through the Oral, Personal and Home Care, and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.